Astrazeneca Pharma India Ltd
BSE:
NSE:ASTRAZEN
ASTRAZEN Share Price
BSE:
NSE:ASTRAZEN
Pharmaceuticals
Small Cap
₹-
0 (0%)
Market Cap
₹17,575.88Cr
PE Ratio
136.54
Astrazeneca Pharma India Ltd Performance
▲
▲
▲
▲
Astrazeneca Pharma India Ltd Fundamentals
Astrazeneca Pharma India Ltd Delivery and Volume
About Astrazeneca Pharma India Ltd
AstraZeneca Pharma India (APIL) was incorporated on July 11, 1979. The Company is engaged in the business of manufacture, distribution and marketing of pharmaceutical products and co-ordinates clinical trial services with an overseas group company. The major therapy areas where the company operates
| Name | Designation |
|---|---|
| Narayan K Seshadri | Chairman & Independent Directo |
| Revathy Ashok | Non-Exec. & Independent Dir. |
| Shilpa Divekar Nirula | Non-Exec. & Independent Dir. |
| Sanjeev Panchal | Managing Director |
| Hooi Bien Chuah | Non Executive Director |
| Sylvia Lorena Varela Ramon | Non Executive Director |
| Bhavana Agrawal | Executive Director |
News and Events...
Top Gainers Today
View All
Top Losers Today
View All
Astrazeneca Pharma India Ltd FAQs
How do I Buy Astrazeneca Pharma India Ltd Shares?
By opening a demat account and having your KYC papers confirmed online, you may simply purchase Astrazeneca Pharma India Ltd shares in BlinkX.
What is the Share Price of Astrazeneca Pharma India Ltd?
The share price of any stock is volatile and changes during the day due to a variety of variables. Astrazeneca Pharma India Ltd's share price is ₹7033.1 as of 2025-01-14.
What is the PE ratio of Astrazeneca Pharma India Ltd?
Astrazeneca Pharma India Ltd's P/E ratio is 136.54 times as of 2025-01-14.
What is the PB ratio of Astrazeneca Pharma India Ltd?
Astrazeneca Pharma India Ltd's most recent financial reports indicate a price-to-book ratio of 25.87, showing the company's stock market valuation in relation to the value of its real assets.
What is the Market Cap of Astrazeneca Pharma India Ltd?
Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Astrazeneca Pharma India Ltd's market capitalization is ₹17575.88 Cr as on 2025-01-14.
What is the ROE of Astrazeneca Pharma India Ltd?
The current financial records of Astrazeneca Pharma India Ltd show a 24.84% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.
What is the Total Asset of Astrazeneca Pharma India Ltd?
According to Astrazeneca Pharma India Ltd's most recent financial filings, the company has a total asset value of ₹955.02, which includes current and non-current assets such as inventory, cash, properties, and equipment.
What is the 52-week high and Low of Astrazeneca Pharma India Ltd?
The 52-week high/low price of a Astrazeneca Pharma India Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Astrazeneca Pharma India Ltd's 52-week high and low as of 2025-01-14 are ₹7134 and ₹6886, respectively.
